Global Digital Respiratory Device Market

Digital Respiratory Device Comprehensive Study by Type (Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers), Diagnostic Devices (Spirometers, Asthma Monitors, Others)), Indication (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), Infectious Diseases, Others), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), End User (Hospital, Home Care) Players and Region - Global Market Outlook to 2028

Digital Respiratory Device Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Digital Respiratory Device
Digital respiratory devices are connected to smartphone applications or other data collection modules. These devices are used in the treatment and monitoring of asthma, chronic obstructive pulmonary diseases (COPD), and other respiratory diseases. These technologically advanced devices enable patients and physicians to monitor, record, and track the dose recording during the treatment.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Digital Respiratory Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

3M (United States), Adherium (New Zealand), Capsule Technologies (United States), Cohero Health (United States), Novartis AG (Switzerland), ResMed (United States), Propeller Health (United States), Sensiron AG (Switzerland), Teva Pharmaceuticals Industries (Israel) and Amiko Digital Health (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are AstraZeneca (United Kingdom), Boehringer Ingelheim International GmbH (Germany) and GlaxoSmithKline (United Kingdom).

Segmentation Overview
AMA Research has segmented the market of Global Digital Respiratory Device market by Type (Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers) and Diagnostic Devices (Spirometers, Asthma Monitors, Others)) and Region.



On the basis of geography, the market of Digital Respiratory Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Indication, the sub-segment i.e. Asthma will boost the Digital Respiratory Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online Pharmacies will boost the Digital Respiratory Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Digital Respiratory Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Demand for Home Care Digital Respiratory Devices and Rising New Product Launch and Approval

Market Growth Drivers:
Rising Prevalence of Respiratory Diseases, Outbreak of Infectious Diseases Affecting Respiratory System and Increasing Adoption of Digital Technology Among Individuals

Challenges:
Availability of Low-Cost Products From Local Manufacturers and Issues Related to The Accuracy and Reliability of the Device

Restraints:
High Cost Associated with Digital Respiratory Devices

Opportunities:
Improvement in the Healthcare Infrastructure in Emerging Economies and High Growth in Developing Countries Across APAC and Latin America

Market Leaders and their expansionary development strategies
In October 2023, Propeller Health partners with asthma management platform Propeller Health to offer a comprehensive asthma management solution combining medication adherence tracking and symptom monitoring.
In May 2023, Propeller Health FDA Clearance for Propeller Platform with Albuterol Inhaler Sensor. This sensor attaches to your inhaler and tracks usage data, helping patients manage their asthma better.


Key Target Audience
Manufacturers of Digital Respiratory Device, Suppliers of Digital Respiratory Device, Wholesalers, Distributors, and Retailers of Digital Respiratory Device, Raw Material Suppliers, Healthcare Industry, Regulatory Bodies, Governmental Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers)
  • Diagnostic Devices (Spirometers, Asthma Monitors, Others)
By Indication
  • Asthma
  • Chronic Obstructive Pulmonary Diseases (COPD)
  • Infectious Diseases
  • Others

By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

By End User
  • Hospital
  • Home Care

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Respiratory Diseases
      • 3.2.2. Outbreak of Infectious Diseases Affecting Respiratory System
      • 3.2.3. Increasing Adoption of Digital Technology Among Individuals
    • 3.3. Market Challenges
      • 3.3.1. Availability of Low-Cost Products From Local Manufacturers
      • 3.3.2. Issues Related to The Accuracy and Reliability of the Device
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Home Care Digital Respiratory Devices
      • 3.4.2. Rising New Product Launch and Approval
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Respiratory Device, by Type, Indication, Distribution Channel, End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Respiratory Device (Value)
      • 5.2.1. Global Digital Respiratory Device by: Type (Value)
        • 5.2.1.1. Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers)
        • 5.2.1.2. Diagnostic Devices (Spirometers, Asthma Monitors, Others)
      • 5.2.2. Global Digital Respiratory Device by: Indication (Value)
        • 5.2.2.1. Asthma
        • 5.2.2.2. Chronic Obstructive Pulmonary Diseases (COPD)
        • 5.2.2.3. Infectious Diseases
        • 5.2.2.4. Others
      • 5.2.3. Global Digital Respiratory Device by: Distribution Channel (Value)
        • 5.2.3.1. Online Pharmacies
        • 5.2.3.2. Hospital Pharmacies
        • 5.2.3.3. Retail Pharmacies
      • 5.2.4. Global Digital Respiratory Device by: End User (Value)
        • 5.2.4.1. Hospital
        • 5.2.4.2. Home Care
      • 5.2.5. Global Digital Respiratory Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Digital Respiratory Device (Volume)
      • 5.3.1. Global Digital Respiratory Device by: Type (Volume)
        • 5.3.1.1. Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers)
        • 5.3.1.2. Diagnostic Devices (Spirometers, Asthma Monitors, Others)
      • 5.3.2. Global Digital Respiratory Device by: Indication (Volume)
        • 5.3.2.1. Asthma
        • 5.3.2.2. Chronic Obstructive Pulmonary Diseases (COPD)
        • 5.3.2.3. Infectious Diseases
        • 5.3.2.4. Others
      • 5.3.3. Global Digital Respiratory Device by: Distribution Channel (Volume)
        • 5.3.3.1. Online Pharmacies
        • 5.3.3.2. Hospital Pharmacies
        • 5.3.3.3. Retail Pharmacies
      • 5.3.4. Global Digital Respiratory Device by: End User (Volume)
        • 5.3.4.1. Hospital
        • 5.3.4.2. Home Care
      • 5.3.5. Global Digital Respiratory Device Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Digital Respiratory Device (Price)
      • 5.4.1. Global Digital Respiratory Device by: Type (Price)
  • 6. Digital Respiratory Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Adherium (New Zealand)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Capsule Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cohero Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Novartis AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ResMed (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Propeller Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sensiron AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teva Pharmaceuticals Industries (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Amiko Digital Health (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Digital Respiratory Device Sale, by Type, Indication, Distribution Channel, End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Respiratory Device (Value)
      • 7.2.1. Global Digital Respiratory Device by: Type (Value)
        • 7.2.1.1. Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers)
        • 7.2.1.2. Diagnostic Devices (Spirometers, Asthma Monitors, Others)
      • 7.2.2. Global Digital Respiratory Device by: Indication (Value)
        • 7.2.2.1. Asthma
        • 7.2.2.2. Chronic Obstructive Pulmonary Diseases (COPD)
        • 7.2.2.3. Infectious Diseases
        • 7.2.2.4. Others
      • 7.2.3. Global Digital Respiratory Device by: Distribution Channel (Value)
        • 7.2.3.1. Online Pharmacies
        • 7.2.3.2. Hospital Pharmacies
        • 7.2.3.3. Retail Pharmacies
      • 7.2.4. Global Digital Respiratory Device by: End User (Value)
        • 7.2.4.1. Hospital
        • 7.2.4.2. Home Care
      • 7.2.5. Global Digital Respiratory Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Digital Respiratory Device (Volume)
      • 7.3.1. Global Digital Respiratory Device by: Type (Volume)
        • 7.3.1.1. Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers)
        • 7.3.1.2. Diagnostic Devices (Spirometers, Asthma Monitors, Others)
      • 7.3.2. Global Digital Respiratory Device by: Indication (Volume)
        • 7.3.2.1. Asthma
        • 7.3.2.2. Chronic Obstructive Pulmonary Diseases (COPD)
        • 7.3.2.3. Infectious Diseases
        • 7.3.2.4. Others
      • 7.3.3. Global Digital Respiratory Device by: Distribution Channel (Volume)
        • 7.3.3.1. Online Pharmacies
        • 7.3.3.2. Hospital Pharmacies
        • 7.3.3.3. Retail Pharmacies
      • 7.3.4. Global Digital Respiratory Device by: End User (Volume)
        • 7.3.4.1. Hospital
        • 7.3.4.2. Home Care
      • 7.3.5. Global Digital Respiratory Device Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Digital Respiratory Device (Price)
      • 7.4.1. Global Digital Respiratory Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Respiratory Device: by Type(USD Million)
  • Table 2. Digital Respiratory Device Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers) , by Region USD Million (2017-2022)
  • Table 3. Digital Respiratory Device Diagnostic Devices (Spirometers, Asthma Monitors, Others) , by Region USD Million (2017-2022)
  • Table 4. Digital Respiratory Device: by Indication(USD Million)
  • Table 5. Digital Respiratory Device Asthma , by Region USD Million (2017-2022)
  • Table 6. Digital Respiratory Device Chronic Obstructive Pulmonary Diseases (COPD) , by Region USD Million (2017-2022)
  • Table 7. Digital Respiratory Device Infectious Diseases , by Region USD Million (2017-2022)
  • Table 8. Digital Respiratory Device Others , by Region USD Million (2017-2022)
  • Table 9. Digital Respiratory Device: by Distribution Channel(USD Million)
  • Table 10. Digital Respiratory Device Online Pharmacies , by Region USD Million (2017-2022)
  • Table 11. Digital Respiratory Device Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 12. Digital Respiratory Device Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 13. Digital Respiratory Device: by End User(USD Million)
  • Table 14. Digital Respiratory Device Hospital , by Region USD Million (2017-2022)
  • Table 15. Digital Respiratory Device Home Care , by Region USD Million (2017-2022)
  • Table 16. South America Digital Respiratory Device, by Country USD Million (2017-2022)
  • Table 17. South America Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 18. South America Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 19. South America Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 20. South America Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 21. Brazil Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 22. Brazil Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 23. Brazil Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 24. Brazil Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 25. Argentina Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 26. Argentina Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 27. Argentina Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 28. Argentina Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 29. Rest of South America Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 31. Rest of South America Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 32. Rest of South America Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 33. Asia Pacific Digital Respiratory Device, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 36. Asia Pacific Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 37. Asia Pacific Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 38. China Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 39. China Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 40. China Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 41. China Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 42. Japan Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 43. Japan Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 44. Japan Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 45. Japan Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 46. India Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 47. India Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 48. India Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 49. India Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 50. South Korea Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 51. South Korea Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 52. South Korea Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 53. South Korea Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 54. Taiwan Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 55. Taiwan Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 56. Taiwan Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 57. Taiwan Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 58. Australia Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 59. Australia Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 60. Australia Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 61. Australia Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 66. Europe Digital Respiratory Device, by Country USD Million (2017-2022)
  • Table 67. Europe Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 68. Europe Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 69. Europe Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 70. Europe Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 71. Germany Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 72. Germany Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 73. Germany Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 74. Germany Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 75. France Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 76. France Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 77. France Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 78. France Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 79. Italy Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 80. Italy Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 81. Italy Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 82. Italy Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 83. United Kingdom Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 85. United Kingdom Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 86. United Kingdom Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 87. Netherlands Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 88. Netherlands Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 89. Netherlands Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 90. Netherlands Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 91. Rest of Europe Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 93. Rest of Europe Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 94. Rest of Europe Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 95. MEA Digital Respiratory Device, by Country USD Million (2017-2022)
  • Table 96. MEA Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 97. MEA Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 98. MEA Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 99. MEA Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 100. Middle East Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 101. Middle East Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 102. Middle East Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 103. Middle East Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 104. Africa Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 105. Africa Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 106. Africa Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 107. Africa Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 108. North America Digital Respiratory Device, by Country USD Million (2017-2022)
  • Table 109. North America Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 110. North America Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 111. North America Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 112. North America Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 113. United States Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 114. United States Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 115. United States Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 116. United States Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 117. Canada Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 118. Canada Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 119. Canada Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 120. Canada Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 121. Mexico Digital Respiratory Device, by Type USD Million (2017-2022)
  • Table 122. Mexico Digital Respiratory Device, by Indication USD Million (2017-2022)
  • Table 123. Mexico Digital Respiratory Device, by Distribution Channel USD Million (2017-2022)
  • Table 124. Mexico Digital Respiratory Device, by End User USD Million (2017-2022)
  • Table 125. Digital Respiratory Device Sales: by Type(Unit)
  • Table 126. Digital Respiratory Device Sales Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers) , by Region Unit (2017-2022)
  • Table 127. Digital Respiratory Device Sales Diagnostic Devices (Spirometers, Asthma Monitors, Others) , by Region Unit (2017-2022)
  • Table 128. Digital Respiratory Device Sales: by Indication(Unit)
  • Table 129. Digital Respiratory Device Sales Asthma , by Region Unit (2017-2022)
  • Table 130. Digital Respiratory Device Sales Chronic Obstructive Pulmonary Diseases (COPD) , by Region Unit (2017-2022)
  • Table 131. Digital Respiratory Device Sales Infectious Diseases , by Region Unit (2017-2022)
  • Table 132. Digital Respiratory Device Sales Others , by Region Unit (2017-2022)
  • Table 133. Digital Respiratory Device Sales: by Distribution Channel(Unit)
  • Table 134. Digital Respiratory Device Sales Online Pharmacies , by Region Unit (2017-2022)
  • Table 135. Digital Respiratory Device Sales Hospital Pharmacies , by Region Unit (2017-2022)
  • Table 136. Digital Respiratory Device Sales Retail Pharmacies , by Region Unit (2017-2022)
  • Table 137. Digital Respiratory Device Sales: by End User(Unit)
  • Table 138. Digital Respiratory Device Sales Hospital , by Region Unit (2017-2022)
  • Table 139. Digital Respiratory Device Sales Home Care , by Region Unit (2017-2022)
  • Table 140. South America Digital Respiratory Device Sales, by Country Unit (2017-2022)
  • Table 141. South America Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 142. South America Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 143. South America Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 144. South America Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 145. Brazil Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 146. Brazil Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 147. Brazil Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 148. Brazil Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 149. Argentina Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 150. Argentina Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 151. Argentina Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 152. Argentina Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 153. Rest of South America Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 154. Rest of South America Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 155. Rest of South America Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 156. Rest of South America Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 157. Asia Pacific Digital Respiratory Device Sales, by Country Unit (2017-2022)
  • Table 158. Asia Pacific Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 159. Asia Pacific Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 160. Asia Pacific Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 161. Asia Pacific Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 162. China Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 163. China Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 164. China Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 165. China Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 166. Japan Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 167. Japan Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 168. Japan Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 169. Japan Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 170. India Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 171. India Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 172. India Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 173. India Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 174. South Korea Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 175. South Korea Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 176. South Korea Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 177. South Korea Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 178. Taiwan Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 179. Taiwan Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 180. Taiwan Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 181. Taiwan Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 182. Australia Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 183. Australia Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 184. Australia Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 185. Australia Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 186. Rest of Asia-Pacific Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 187. Rest of Asia-Pacific Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 188. Rest of Asia-Pacific Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 189. Rest of Asia-Pacific Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 190. Europe Digital Respiratory Device Sales, by Country Unit (2017-2022)
  • Table 191. Europe Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 192. Europe Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 193. Europe Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 194. Europe Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 195. Germany Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 196. Germany Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 197. Germany Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 198. Germany Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 199. France Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 200. France Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 201. France Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 202. France Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 203. Italy Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 204. Italy Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 205. Italy Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 206. Italy Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 207. United Kingdom Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 208. United Kingdom Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 209. United Kingdom Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 210. United Kingdom Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 211. Netherlands Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 212. Netherlands Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 213. Netherlands Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 214. Netherlands Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 215. Rest of Europe Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 216. Rest of Europe Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 217. Rest of Europe Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 218. Rest of Europe Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 219. MEA Digital Respiratory Device Sales, by Country Unit (2017-2022)
  • Table 220. MEA Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 221. MEA Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 222. MEA Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 223. MEA Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 224. Middle East Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 225. Middle East Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 226. Middle East Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 227. Middle East Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 228. Africa Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 229. Africa Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 230. Africa Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 231. Africa Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 232. North America Digital Respiratory Device Sales, by Country Unit (2017-2022)
  • Table 233. North America Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 234. North America Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 235. North America Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 236. North America Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 237. United States Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 238. United States Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 239. United States Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 240. United States Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 241. Canada Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 242. Canada Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 243. Canada Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 244. Canada Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 245. Mexico Digital Respiratory Device Sales, by Type Unit (2017-2022)
  • Table 246. Mexico Digital Respiratory Device Sales, by Indication Unit (2017-2022)
  • Table 247. Mexico Digital Respiratory Device Sales, by Distribution Channel Unit (2017-2022)
  • Table 248. Mexico Digital Respiratory Device Sales, by End User Unit (2017-2022)
  • Table 249. Digital Respiratory Device: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Digital Respiratory Device: by Type(USD Million)
  • Table 261. Digital Respiratory Device Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers) , by Region USD Million (2023-2028)
  • Table 262. Digital Respiratory Device Diagnostic Devices (Spirometers, Asthma Monitors, Others) , by Region USD Million (2023-2028)
  • Table 263. Digital Respiratory Device: by Indication(USD Million)
  • Table 264. Digital Respiratory Device Asthma , by Region USD Million (2023-2028)
  • Table 265. Digital Respiratory Device Chronic Obstructive Pulmonary Diseases (COPD) , by Region USD Million (2023-2028)
  • Table 266. Digital Respiratory Device Infectious Diseases , by Region USD Million (2023-2028)
  • Table 267. Digital Respiratory Device Others , by Region USD Million (2023-2028)
  • Table 268. Digital Respiratory Device: by Distribution Channel(USD Million)
  • Table 269. Digital Respiratory Device Online Pharmacies , by Region USD Million (2023-2028)
  • Table 270. Digital Respiratory Device Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 271. Digital Respiratory Device Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 272. Digital Respiratory Device: by End User(USD Million)
  • Table 273. Digital Respiratory Device Hospital , by Region USD Million (2023-2028)
  • Table 274. Digital Respiratory Device Home Care , by Region USD Million (2023-2028)
  • Table 275. South America Digital Respiratory Device, by Country USD Million (2023-2028)
  • Table 276. South America Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 277. South America Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 278. South America Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 279. South America Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 280. Brazil Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 281. Brazil Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 282. Brazil Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 283. Brazil Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 284. Argentina Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 285. Argentina Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 286. Argentina Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 287. Argentina Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 288. Rest of South America Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 289. Rest of South America Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 290. Rest of South America Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 291. Rest of South America Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 292. Asia Pacific Digital Respiratory Device, by Country USD Million (2023-2028)
  • Table 293. Asia Pacific Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 294. Asia Pacific Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 295. Asia Pacific Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 296. Asia Pacific Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 297. China Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 298. China Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 299. China Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 300. China Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 301. Japan Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 302. Japan Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 303. Japan Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 304. Japan Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 305. India Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 306. India Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 307. India Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 308. India Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 309. South Korea Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 310. South Korea Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 311. South Korea Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 312. South Korea Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 313. Taiwan Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 314. Taiwan Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 315. Taiwan Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 316. Taiwan Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 317. Australia Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 318. Australia Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 319. Australia Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 320. Australia Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 321. Rest of Asia-Pacific Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 322. Rest of Asia-Pacific Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 323. Rest of Asia-Pacific Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 324. Rest of Asia-Pacific Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 325. Europe Digital Respiratory Device, by Country USD Million (2023-2028)
  • Table 326. Europe Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 327. Europe Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 328. Europe Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 329. Europe Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 330. Germany Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 331. Germany Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 332. Germany Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 333. Germany Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 334. France Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 335. France Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 336. France Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 337. France Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 338. Italy Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 339. Italy Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 340. Italy Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 341. Italy Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 342. United Kingdom Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 343. United Kingdom Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 344. United Kingdom Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 345. United Kingdom Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 346. Netherlands Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 347. Netherlands Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 348. Netherlands Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 349. Netherlands Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 350. Rest of Europe Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 351. Rest of Europe Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 352. Rest of Europe Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 353. Rest of Europe Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 354. MEA Digital Respiratory Device, by Country USD Million (2023-2028)
  • Table 355. MEA Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 356. MEA Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 357. MEA Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 358. MEA Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 359. Middle East Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 360. Middle East Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 361. Middle East Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 362. Middle East Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 363. Africa Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 364. Africa Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 365. Africa Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 366. Africa Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 367. North America Digital Respiratory Device, by Country USD Million (2023-2028)
  • Table 368. North America Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 369. North America Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 370. North America Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 371. North America Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 372. United States Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 373. United States Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 374. United States Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 375. United States Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 376. Canada Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 377. Canada Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 378. Canada Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 379. Canada Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 380. Mexico Digital Respiratory Device, by Type USD Million (2023-2028)
  • Table 381. Mexico Digital Respiratory Device, by Indication USD Million (2023-2028)
  • Table 382. Mexico Digital Respiratory Device, by Distribution Channel USD Million (2023-2028)
  • Table 383. Mexico Digital Respiratory Device, by End User USD Million (2023-2028)
  • Table 384. Digital Respiratory Device Sales: by Type(Unit)
  • Table 385. Digital Respiratory Device Sales Therapeutic Devices (Inhalers, Smart Inhalers, Adaptors for Conventional Inhalers, Nebulizers) , by Region Unit (2023-2028)
  • Table 386. Digital Respiratory Device Sales Diagnostic Devices (Spirometers, Asthma Monitors, Others) , by Region Unit (2023-2028)
  • Table 387. Digital Respiratory Device Sales: by Indication(Unit)
  • Table 388. Digital Respiratory Device Sales Asthma , by Region Unit (2023-2028)
  • Table 389. Digital Respiratory Device Sales Chronic Obstructive Pulmonary Diseases (COPD) , by Region Unit (2023-2028)
  • Table 390. Digital Respiratory Device Sales Infectious Diseases , by Region Unit (2023-2028)
  • Table 391. Digital Respiratory Device Sales Others , by Region Unit (2023-2028)
  • Table 392. Digital Respiratory Device Sales: by Distribution Channel(Unit)
  • Table 393. Digital Respiratory Device Sales Online Pharmacies , by Region Unit (2023-2028)
  • Table 394. Digital Respiratory Device Sales Hospital Pharmacies , by Region Unit (2023-2028)
  • Table 395. Digital Respiratory Device Sales Retail Pharmacies , by Region Unit (2023-2028)
  • Table 396. Digital Respiratory Device Sales: by End User(Unit)
  • Table 397. Digital Respiratory Device Sales Hospital , by Region Unit (2023-2028)
  • Table 398. Digital Respiratory Device Sales Home Care , by Region Unit (2023-2028)
  • Table 399. South America Digital Respiratory Device Sales, by Country Unit (2023-2028)
  • Table 400. South America Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 401. South America Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 402. South America Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 403. South America Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 404. Brazil Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 405. Brazil Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 406. Brazil Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 407. Brazil Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 408. Argentina Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 409. Argentina Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 410. Argentina Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 411. Argentina Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 412. Rest of South America Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 413. Rest of South America Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 414. Rest of South America Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 415. Rest of South America Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 416. Asia Pacific Digital Respiratory Device Sales, by Country Unit (2023-2028)
  • Table 417. Asia Pacific Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 418. Asia Pacific Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 419. Asia Pacific Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 420. Asia Pacific Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 421. China Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 422. China Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 423. China Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 424. China Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 425. Japan Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 426. Japan Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 427. Japan Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 428. Japan Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 429. India Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 430. India Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 431. India Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 432. India Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 433. South Korea Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 434. South Korea Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 435. South Korea Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 436. South Korea Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 437. Taiwan Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 438. Taiwan Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 439. Taiwan Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 440. Taiwan Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 441. Australia Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 442. Australia Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 443. Australia Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 444. Australia Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 445. Rest of Asia-Pacific Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 446. Rest of Asia-Pacific Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 447. Rest of Asia-Pacific Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 448. Rest of Asia-Pacific Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 449. Europe Digital Respiratory Device Sales, by Country Unit (2023-2028)
  • Table 450. Europe Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 451. Europe Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 452. Europe Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 453. Europe Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 454. Germany Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 455. Germany Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 456. Germany Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 457. Germany Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 458. France Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 459. France Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 460. France Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 461. France Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 462. Italy Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 463. Italy Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 464. Italy Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 465. Italy Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 466. United Kingdom Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 467. United Kingdom Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 468. United Kingdom Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 469. United Kingdom Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 470. Netherlands Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 471. Netherlands Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 472. Netherlands Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 473. Netherlands Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 474. Rest of Europe Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 475. Rest of Europe Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 476. Rest of Europe Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 477. Rest of Europe Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 478. MEA Digital Respiratory Device Sales, by Country Unit (2023-2028)
  • Table 479. MEA Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 480. MEA Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 481. MEA Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 482. MEA Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 483. Middle East Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 484. Middle East Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 485. Middle East Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 486. Middle East Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 487. Africa Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 488. Africa Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 489. Africa Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 490. Africa Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 491. North America Digital Respiratory Device Sales, by Country Unit (2023-2028)
  • Table 492. North America Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 493. North America Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 494. North America Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 495. North America Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 496. United States Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 497. United States Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 498. United States Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 499. United States Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 500. Canada Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 501. Canada Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 502. Canada Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 503. Canada Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 504. Mexico Digital Respiratory Device Sales, by Type Unit (2023-2028)
  • Table 505. Mexico Digital Respiratory Device Sales, by Indication Unit (2023-2028)
  • Table 506. Mexico Digital Respiratory Device Sales, by Distribution Channel Unit (2023-2028)
  • Table 507. Mexico Digital Respiratory Device Sales, by End User Unit (2023-2028)
  • Table 508. Digital Respiratory Device: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Respiratory Device: by Type USD Million (2017-2022)
  • Figure 5. Global Digital Respiratory Device: by Indication USD Million (2017-2022)
  • Figure 6. Global Digital Respiratory Device: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Digital Respiratory Device: by End User USD Million (2017-2022)
  • Figure 8. South America Digital Respiratory Device Share (%), by Country
  • Figure 9. Asia Pacific Digital Respiratory Device Share (%), by Country
  • Figure 10. Europe Digital Respiratory Device Share (%), by Country
  • Figure 11. MEA Digital Respiratory Device Share (%), by Country
  • Figure 12. North America Digital Respiratory Device Share (%), by Country
  • Figure 13. Global Digital Respiratory Device: by Type Unit (2017-2022)
  • Figure 14. Global Digital Respiratory Device: by Indication Unit (2017-2022)
  • Figure 15. Global Digital Respiratory Device: by Distribution Channel Unit (2017-2022)
  • Figure 16. Global Digital Respiratory Device: by End User Unit (2017-2022)
  • Figure 17. South America Digital Respiratory Device Share (%), by Country
  • Figure 18. Asia Pacific Digital Respiratory Device Share (%), by Country
  • Figure 19. Europe Digital Respiratory Device Share (%), by Country
  • Figure 20. MEA Digital Respiratory Device Share (%), by Country
  • Figure 21. North America Digital Respiratory Device Share (%), by Country
  • Figure 22. Global Digital Respiratory Device: by Type USD/Units (2017-2022)
  • Figure 23. Global Digital Respiratory Device share by Players 2022 (%)
  • Figure 24. Global Digital Respiratory Device share by Players (Top 3) 2022(%)
  • Figure 25. Global Digital Respiratory Device share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 28. 3M (United States) Revenue: by Geography 2022
  • Figure 29. Adherium (New Zealand) Revenue, Net Income and Gross profit
  • Figure 30. Adherium (New Zealand) Revenue: by Geography 2022
  • Figure 31. Capsule Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 32. Capsule Technologies (United States) Revenue: by Geography 2022
  • Figure 33. Cohero Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cohero Health (United States) Revenue: by Geography 2022
  • Figure 35. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis AG (Switzerland) Revenue: by Geography 2022
  • Figure 37. ResMed (United States) Revenue, Net Income and Gross profit
  • Figure 38. ResMed (United States) Revenue: by Geography 2022
  • Figure 39. Propeller Health (United States) Revenue, Net Income and Gross profit
  • Figure 40. Propeller Health (United States) Revenue: by Geography 2022
  • Figure 41. Sensiron AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Sensiron AG (Switzerland) Revenue: by Geography 2022
  • Figure 43. Teva Pharmaceuticals Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Teva Pharmaceuticals Industries (Israel) Revenue: by Geography 2022
  • Figure 45. Amiko Digital Health (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 46. Amiko Digital Health (United Kingdom) Revenue: by Geography 2022
  • Figure 47. Global Digital Respiratory Device: by Type USD Million (2023-2028)
  • Figure 48. Global Digital Respiratory Device: by Indication USD Million (2023-2028)
  • Figure 49. Global Digital Respiratory Device: by Distribution Channel USD Million (2023-2028)
  • Figure 50. Global Digital Respiratory Device: by End User USD Million (2023-2028)
  • Figure 51. South America Digital Respiratory Device Share (%), by Country
  • Figure 52. Asia Pacific Digital Respiratory Device Share (%), by Country
  • Figure 53. Europe Digital Respiratory Device Share (%), by Country
  • Figure 54. MEA Digital Respiratory Device Share (%), by Country
  • Figure 55. North America Digital Respiratory Device Share (%), by Country
  • Figure 56. Global Digital Respiratory Device: by Type Unit (2023-2028)
  • Figure 57. Global Digital Respiratory Device: by Indication Unit (2023-2028)
  • Figure 58. Global Digital Respiratory Device: by Distribution Channel Unit (2023-2028)
  • Figure 59. Global Digital Respiratory Device: by End User Unit (2023-2028)
  • Figure 60. South America Digital Respiratory Device Share (%), by Country
  • Figure 61. Asia Pacific Digital Respiratory Device Share (%), by Country
  • Figure 62. Europe Digital Respiratory Device Share (%), by Country
  • Figure 63. MEA Digital Respiratory Device Share (%), by Country
  • Figure 64. North America Digital Respiratory Device Share (%), by Country
  • Figure 65. Global Digital Respiratory Device: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • 3M (United States)
  • Adherium (New Zealand)
  • Capsule Technologies (United States)
  • Cohero Health (United States)
  • Novartis AG (Switzerland)
  • ResMed (United States)
  • Propeller Health (United States)
  • Sensiron AG (Switzerland)
  • Teva Pharmaceuticals Industries (Israel)
  • Amiko Digital Health (United Kingdom)
Additional players considered in the study are as follows:
AstraZeneca (United Kingdom) , Boehringer Ingelheim International GmbH (Germany) , GlaxoSmithKline (United Kingdom)
Select User Access Type

Key Highlights of Report


Dec 2023 212 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Respiratory Device Market Quantitative research analysis
Global Digital Respiratory Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as 3M (United States), Adherium (New Zealand), Capsule Technologies (United States), Cohero Health (United States), Novartis AG (Switzerland), ResMed (United States), Propeller Health (United States), Sensiron AG (Switzerland), Teva Pharmaceuticals Industries (Israel) and Amiko Digital Health (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Demand for Home Care Digital Respiratory Devices " is seen as one of major influencing trends for Digital Respiratory Device Market during projected period 2022-2028.
The Digital Respiratory Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Digital Respiratory Device Market Report?

Have a Query? Click Here

Other Related Reports

Spinal Cord Stimulation (Scs) Devices Comprehensive Study by Type (Conventional implantable pulse generator (IPG), Rechargeable IPG, Radiofrequency stimulator), Application (Back Pain, Post-Surgical ...
$ 3800
Body Temperature Monitoring Comprehensive Study by Type (Digital Thermometers, IR Temporal Artery Thermometers, Mercury Thermometers, Non-Invasive, Other), Application (Oral, Rectum, Ear, Forehead), ...
$ 3650
Medical Suction Device Comprehensive Study by Type (Ac-Powered Devices, Battery-Powered Devices, Dual-Powered Devices, Manually Operated Devices), Application (Respiratory, Gastric, Wound Suction, De...
$ 3750
Medical Membrane Devices Comprehensive Study by Type (Dialyzers, Blood oxygenators, IV filters, Blood microfilters, Blood/apheresis filters, Others), Application (Cardiovascular diseases, Respiratory...
$ 3450
Hearing Aid Adjustment Systems Comprehensive Study by Type (Fitting Analysis, Speech Mapping, Acoustic Testing, Programming), Application (Men, Women, Children), Patient Type (Adult, Pediatric), Typ...
$ 3450
Bursitis Treatment Comprehensive Study by Type (Corticosteroids {Dexamethasone, Prednisolone}, Antibiotic {Flucloxacillin, Erythromycin, Clarithromycin}, Analgesics, Others), Diagnosis (X-Ray, Ultra...
$ 3750